Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01019200 · ClinicalTrials.gov registry record
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 210
- Enrollment target
NCT01019200 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 210 participants.
The verdict
NCT01019200 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
Study Summary
Psoriasis patients are known to be at increased risk for heart disease. This may be due to the increased prevalence of cardiovascular disease risk factors in this population, including high blood pressure, diabetes, obesity, and high cholesterol. Although cholesterol levels are known to be altered in psoriasis, most studies have used standard lipid profiles to measure cholesterol. These tests indirectly measure LDL (bad cholesterol) and become less accurate when triglyceride levels are high, as often see in individuals with psoriasis. We have designed a case-control study that uses a more specific and detailed cholesterol test to measure serum lipid levels in psoriasis patients, allowing for more accurate determination of LDL and better assessment of the lipid-contribution to cardiovascular risk. We will also measure other markers of inflammation that may contribute to cardiovascular disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2009-11 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01019200
The ClinicalTrials.gov registry entry for NCT01019200 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01019200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01019200 about?
NCT01019200 is a clinical study titled "Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis". Psoriasis patients are known to be at increased risk for heart disease. This may be due to the increased prevalence of cardiovascular disease risk factors in this population, including high blood pressure, diabetes, obesity, and high cholesterol. Although cholesterol levels are known to be altered i...
What is the current status of trial NCT01019200?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2009-11. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01019200?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.